Abstract
刘玄华,朱秋映,苏锦明,孟琴,周信娟,沈智勇,唐振柱,杨文敏,阮玉华,邵一鸣.广西壮族自治区2008-2015年艾滋病病毒感染者基线CD4+T淋巴细胞计数水平对抗病毒治疗脱失的影响[J].Chinese journal of Epidemiology,2018,39(9):1216-1221
广西壮族自治区2008-2015年艾滋病病毒感染者基线CD4+T淋巴细胞计数水平对抗病毒治疗脱失的影响
Effect of baseline CD4+T cell count on drop-out of antiretroviral therapy in HIV infected persons in Guangxi Zhuang Autonomous Region, 2008-2015
Received:January 22, 2018  
DOI:10.3760/cma.j.issn.0254-6450.2018.09.014
KeyWord: 艾滋病病毒感染者  抗病毒治疗  CD4+T淋巴细胞计数  脱失
English Key Word: HIV infected persons  Antiretroviral therapy  CD4+T cell count  Drop-out
FundProject:广西八桂学者艾滋病防控关键技术岗位专项经费
Author NameAffiliationE-mail
Liu Xuanhua Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning 530028, China  
Zhu Qiuying Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning 530028, China  
Su Jinming Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning 530028, China  
Meng Qin Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning 530028, China  
Zhou Xinjuan Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning 530028, China  
Shen Zhiyong Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning 530028, China  
Tang Zhenzhu Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning 530028, China  
Yang Wenmin Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning 530028, China ywm5839@163.com 
Ruan Yuhua National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China  
Shao Yiming National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China  
Hits: 3466
Download times: 1483
Abstract:
      目的 探讨HIV感染者开始抗病毒治疗(ART)时基线CD4+T淋巴细胞计数(CD4)不同水平对治疗脱失的影响。方法 采用回顾性队列研究方法,从艾滋病防治基本信息系统ART库选取2008-2015年广西壮族自治区(广西)首次开始ART、年龄≥18岁的HIV感染者,分析其ART脱失情况,随访时间截至2016年5月30日。采用Cox比例风险模型分析ART时基线CD4不同水平对ART脱失的影响。结果 共计58 502例HIV感染者进入队列,平均脱失比例为4.8/100人年。在控制了年龄、性别、婚姻状况、感染途径、ART前WHO临床分期、初始治疗方案、目前治疗方案、治疗方案改变、ART开始年份等因素后,基线CD4为200~、351~、≥500个/μl组HIV感染者的脱失风险分别是<200个/μl组的1.110(95% CI:1.053~1.171,P<0.001)、1.391(95% CI:1.278~1.514,P<0.001)、1.695(95% CI:1.497~1.918,P<0.001)倍。HIV感染者因为依从性差而停药的比例为56.0%(1 601/2 861)。结论 随着HIV感染者接受ART时CD4水平提高,ART脱失风险明显增加。为减少ART脱失,应充分考虑开始ART时CD4水平,加强依从性宣传教育和治疗机构人员培训。
English Abstract:
      Objective To investigate the effect of baseline CD4+T cell count (CD4) on drop-out of antiretroviral therapy (ART) in HIV infected persons. Methods Retrospective cohort was conducted in this study. HIV infected persons aged ≥ 18 years and receiving free ART for the first time in Guangxi Zhuang Autonomous Region (Guangxi) from 2008 to 2015 were selected from the antiretroviral treatment database of National Comprehensive HIV/AIDS Information System, with follow-up conducted till May 30, 2016. Cause-specific Cox proportional hazard models were used to evaluate effect of different CD4 on the drop-out of ART in the HIV infected persons. Results A total of 58 502 eligible study participants were included in this retrospective cohort study. The average drop-out ratio was 4.8/100 person-years. After controlling the following baseline covariates:age, sex, marital status, route of HIV infection, WHO clinical stage before ART, initial/current ART regiment, ART regiment adjustment, and year of initiating ART for potential confounding, the adjusted HR of drop-out for HIV infected persons with 200-cells/μl, 351-cells/μl and ≥ 500 cells/μl were 1.110 (95% CI:1.053-1.171, P<0.001), 1.391 (95% CI:1.278-1.514, P<0.001) and 1.695 (95% CI:1.497-1.918, P<0.001), respectively, in risk for drop-out compared with those with baseline CD4 <200 cells/μl. Among the HIV infected persons, 56.0% (1 601/2 861) of drug withdrawal was due to poor compliance with medication. Conclusions With the increase of baseline CD4 when initiating ART, the risk for the drop-out in HIV infected persons increased significantly. To further reduce the drop-out of ART, it is important to take CD4 into account in initiating ART and to strengthen the health education on treatment compliancy and training for healthcare providers.
View Fulltext   Html FullText     View/Add Comment  Download reader
Close